Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma-Reference-Cited by-同舟云学术

Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma

Published:2017-02-08 Issue:10 Volume:123 Page:1731-1740
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Tanaka Kosuke¹,Hida Toyoaki¹,Oya Yuko¹,Yoshida Tatsuya¹,Shimizu Junichi¹,Mizuno Tetsuya²,Kuroda Hiroaki²,Sakakura Noriaki²,Yoshimura Kenichi³,Horio Yoshitsugu¹,Sakao Yukinori²,Yatabe Yasushi⁴

Affiliation:

1. Department of Thoracic OncologyAichi Cancer Center HospitalNagoya Japan

2. Department of Thoracic SurgeryAichi Cancer Center HospitalNagoya Japan

3. Department of Biomedical StatisticsInnovative Clinical Research Center, Kanazawa UniversityKanazawa Japan

4. Department of Pathology and Molecular DiagnosticsAichi Cancer Center HospitalNagoya Japan

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.30539

Reference36 articles.

1. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

2. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

3. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

4. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

5. ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different clinicopathological features between young and older patients with pulmonary adenocarcinoma and ground-glass opacity;Scientific Reports;2024-07-08

2. Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer;Frontiers in Immunology;2024-06-21

3. Tackling Non–Small Cell Lung Cancer in Young Adults: From Risk Factors and Genetic Susceptibility to Lung Cancer Profile and Outcomes;American Society of Clinical Oncology Educational Book;2024-06

4. Advancements in the diagnosis and treatment of sub‑centimeter lung cancer in the era of precision medicine (Review);Molecular and Clinical Oncology;2024-02-09

5. Distinguishing EGFR mutant subtypes in stage IA non-small cell lung cancer using the presence status of ground glass opacity and final histologic classification: a systematic review and meta-analysis;Frontiers in Medicine;2023-12-06